ÖZET
Kardiyopleji, hem pediatrik hem de erişkin hastalarda kalbin durdurulmasıyla yapılan cerrahi prosedürlerde, miyokard korumasının ayrılmaz ve gerekli bir yöntemidir. Kalp cerrahisinde, miyokardın korunması için kardiyopleji solüsyonlarıyla uygulanan farmakolojik arrest en yaygın ve geçerli yöntemdir. del Nido kardiyopleji solüsyonu pediatrik kalp cerrahisinde onlarca yıldır kullanılmasına rağmen, yetişkin kalp cerrahisinde kullanımı nispeten yeni bir olgudur. Pediatrik ve infant hastalarda uzun yıllardır yaygın olarak kullanılması nedeniyle daha fazla veri mevcuttur; ancak erişkin hastalarda kullanımına dair veriler daha sınırlıdır. del Nido kardiyopleji solüsyonunun pediatrik kardiyak cerrahide çeşitli yönlerden daha üstün olduğu raporlanmıştır. Bu miyokard koruma tekniğininin farklı yaş gruplarında daha güvenli bir şekilde optimal kullanımını sağlamak için daha fazla kanıta dayalı çalışma gerekmektedir. Bu derlemede farklı yaş gruplarında del Nido kardiyopleji solüsyonun kullanımı ile igili yapılan çalışmalar ele alınmıştır.
References
1
Tschaut Rudolf J, Dreher M, Walczak A, et al. Extracorporeal circulation in theory and practice. Pabst Science Publishers. Lengerich, Germany, 2020.
2
Durandy Y. Pediatric myocardial protection. Curr Opin Cardiol. 2008;23:85-90.
3
Whittaker A, Aboughdir M, Mahbub S, et al. Myocardial protection in cardiac surgery: how limited are the options? A comprehensive literature review. Perfusion. 2021;36:338-351.
4
Chatrath R, Kaul T, Walker D. Myocardial protection during cardioplegia in open-heart surgery: a review. Can Anaesth Soc J. 1980;27:381-388.
5
Cohn LH. Cardiac Surgery in the Adult. Fourth Edition. McGraw Hill Professional, 2012.
6
Sanetra K, Pawlak I, Cisowski M. Del Nido cardioplegia - what is the current evidence? Kardiochir Torakochirurgia Pol. 2018;15:114-118.
7
Jonas RA, Di Nardo J, Laussen RC, et al. Why early primary repair? In Comprehensive Surgical Management of Congenital Heart Disease. London, 2004, pp 3-6.
8
Gravlee GP, Davis RF, Hammon J, et al. Cardiopulmonary Bypass and Mechanical Support: Principles and Practice. Lippincott Williams & Wilkins, 2015.
9
Bretschneider HJ, Hübner G, Knoll D, et al. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg. 1975;16:241-260.
10
Hearse DJ, Stewart DA, Braimbridge MV. Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation. 1976;54:193-202.
11
Braimbridge Mv, Chayen J, Bitensky L, et al. Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg. 1977;74:900-906.
12
Follette DM, Mulder DG, Maloney JV, et al. Advantages of blood cardioplegia over continuous coro- nary perfusion and intermittent ischemia. Experimental and clinical study. J Thorac Cardiovasc Surg. 1978;76:604-619.
13
Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children’s Hospital. J Extra Corpor Technol. 2012;44:98-103.
14
Melrose DG, Dreyer B, Bentall HH, et al. Elective cardiac arrest. The Lancet 1955;266:21-23.
15
Rosenkranz ER, Vinten-Johansen J, Buckberg GD, et al. Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts, with maintenance of arrest by multidose cold blood cardioplegic infusions. J Thorac Cardiovasc Surg. 1982;84:667-677.
16
Bolling K, Kronon M, Allen BS, et al. Myocardial protection in normal and hypoxically stressed neonatal hearts: the superiority of hypocalcemic versus normocalcemic blood cardioplegia. J Thorac Cardiovasc Surg. 1996;112:1193-1201.
17
Morita K, Ihnken K, Buckberg GD, et al. Studies of hypoxemic/reoxygenation injury: Without aortic clamping:: VII. Counteraction of oxidant damage by exogenous antioxidants: Coenzyme Q10. J Thorac Cardiovasc Surg. 1995;110:1221-1227.
18
Jennings RB, Reimer KA. Lethal myocardial ischemic injury. Am J Pathol. 1981;102:241-255.
19
Swanson DK, Pasaoglu I, Berkoff HA, et al. Improved heart preservation with UW preservation solution. J Heart Transplant. 1988;7:456-467.
20
Rebeyka IM, Axford-Gatley RA, Bush BG. Calcium paradox in an in vivo model of multidose cardioplegia and moderate hypothermia. J Thorac Cardiovasc Surg. 1990;99:475-483.
21
O’Blenes SB, Friesen CH, Ali A, et al. Protecting the aged heart during cardiac surgery: The potential benefits of del Nido cardioplegia. J Thorac Cardiovasc Surg. 2011;141:762-769.
22
Valooran GJ, Nair SK, Chandrasekharan K, et al. Del Nido cardioplegia in adult cardiac surgery scopes and concerns. Perfusion. 2016;31:6-14.
23
O’brien JD, Howlett SE, Burton HJ, et al. Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T. Ann Thorac Surg. 2009;87:1517-1524.
24
Kotani Y, Tweddell J, Gruber P, et al. Current cardioplegia practice in pediatric cardiac surgery: a North American multiinstitutional survey. Ann Thorac Surg. 2013;96:923-929.
25
Charette K, Gerrah R, Quaegebeur J, et al. Single dose myocardial protection technique utilizing del Nido cardioplegia solution during congenital heart surgery procedures. Perfusion. 2012;27:98-103.
26
Buel ST, Striker CW, O’Brien JE. del Nido versus St. Thomas cardioplegia solutions: a single-center retrospective analysis of post cross-clamp defibrillation rates. J Extra Corpor Technol. 2016;48:67-70.
27
Talwar S, Bhoje A, Sreenivas V, et al. Comparison of del Nido and St Thomas cardioplegia solutions in pediatric patients: a prospective randomized clinical trial. Semin Thorac Cardiovasc Surg. 2017;29:366-374.
28
Gorjipour F, Dehaki MG, Totonchi Z, et al. Inflammatory cytokine response and cardiac troponin I changes in cardiopulmonary bypass using two cardioplegia solutions; del Nido and modified St. Thomas’: a randomized controlled trial. Perfusion. 2017;32:394-402.
29
Ota T, Yerebakan H, Neely RC, et al. Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution. Perfusion. 2016;31:27-33.
30
Kim K, Ball C, Grady P, et al. Use of del Nido cardioplegia for adult cardiac surgery at the Cleveland Clinic: perfusion implications. J Extra Corpor Technol 2014;46:317-323.
31
Mick SL, Robich MP, Houghtaling PL, et al. del Nido versus Buckberg cardioplegia in adult isolated valve surgery. J Thorac Cardiovasc Surg. 2015;149:626-636.
32
Govindapillai A, Hua R, Rose R, et al. Protecting the aged heart during cardiac surgery: use of del Nido cardioplegia provides superior functional recovery in isolated hearts. J Thorac Cardiovasc Surg. 2013;146:940-948.
33
Mishra P, Jadhav RB, Mohapatra CK, et al. Comparison of del Nido cardioplegia and St. Thomas Hospital solution - two types of cardioplegia in adult cardiac surgery. Kardiochir Torakochirurgia Pol. 2016;13:295-299.
34
Sorabella RA, Akashi H, Yerebakan H, et al. Myocardial protection using del Nido cardioplegia solution in adult reoperative aortic valve surgery. J Card Surg. 2014;29:445-449.
35
Loberman D, Neely RC, Fitzgerald D, et al. Modified del Nido cardioplegia in adult cardiac surgery; safety and efficacy. J Cardiol Curr Res. 2014;1:00042.
36
Ziazadeh D, Mater R, Himelhoch B, et al. Single-dose del Nido cardioplegia in minimally invasive aortic Valve Surgery. Semin Thorac Cardiovasc Surg. 2017;29:471-476.
37
Guajardo Salinas GE, Nutt R, Rodriguez-Araujo G. Del Nido cardioplegia in low risk adults undergoing first time coronary artery bypass surgery. Perfusion. 2017;32:68-73.
38
Timek T, Willekes C, Hulme O, et al. Propensity matched analysis of del Nido cardioplegia in adult coronary artery bypass grafting: initial experience with 100 consecutive patients. Ann Thorac Surg. 2016;101:2237-2241.
39
Ramanathan R, Parrish DW, Armour TK, et al. Use of del Nido cardioplegia in adult cardiac surgery. Thorac Cardiovasc Surg. 2015;63:624-627.
